Retinal Optical Coherence Tomography Features Associated With Incident and Prevalent Parkinson Disease
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology..
BACKGROUND AND OBJECTIVES: Cadaveric studies have shown disease-related neurodegeneration and other morphological abnormalities in the retina of individuals with Parkinson disease (PD); however, it remains unclear whether this can be reliably detected with in vivo imaging. We investigated inner retinal anatomy, measured using optical coherence tomography (OCT), in prevalent PD and subsequently assessed the association of these markers with the development of PD using a prospective research cohort.
METHODS: This cross-sectional analysis used data from 2 studies. For the detection of retinal markers in prevalent PD, we used data from AlzEye, a retrospective cohort of 154,830 patients aged 40 years and older attending secondary care ophthalmic hospitals in London, United Kingdom, between 2008 and 2018. For the evaluation of retinal markers in incident PD, we used data from UK Biobank, a prospective population-based cohort where 67,311 volunteers aged 40-69 years were recruited between 2006 and 2010 and underwent retinal imaging. Macular retinal nerve fiber layer (mRNFL), ganglion cell-inner plexiform layer (GCIPL), and inner nuclear layer (INL) thicknesses were extracted from fovea-centered OCT. Linear mixed-effects models were fitted to examine the association between prevalent PD and retinal thicknesses. Hazard ratios for the association between time to PD diagnosis and retinal thicknesses were estimated using frailty models.
RESULTS: Within the AlzEye cohort, there were 700 individuals with prevalent PD and 105,770 controls (mean age 65.5 ± 13.5 years, 51.7% female). Individuals with prevalent PD had thinner GCIPL (-2.12 μm, 95% CI -3.17 to -1.07, p = 8.2 × 10-5) and INL (-0.99 μm, 95% CI -1.52 to -0.47, p = 2.1 × 10-4). The UK Biobank included 50,405 participants (mean age 56.1 ± 8.2 years, 54.7% female), of whom 53 developed PD at a mean of 2,653 ± 851 days. Thinner GCIPL (hazard ratio [HR] 0.62 per SD increase, 95% CI 0.46-0.84, p = 0.002) and thinner INL (HR 0.70, 95% CI 0.51-0.96, p = 0.026) were also associated with incident PD.
DISCUSSION: Individuals with PD have reduced thickness of the INL and GCIPL of the retina. Involvement of these layers several years before clinical presentation highlight a potential role for retinal imaging for at-risk stratification of PD.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:101 |
|---|---|
| Enthalten in: |
Neurology - 101(2023), 16 vom: 17. Okt., Seite e1581-e1593 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wagner, Siegfried Karl [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 23.10.2023 Date Revised 17.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1212/WNL.0000000000207727 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361032455 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361032455 | ||
| 003 | DE-627 | ||
| 005 | 20231226084303.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1212/WNL.0000000000207727 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1203.xml |
| 035 | |a (DE-627)NLM361032455 | ||
| 035 | |a (NLM)37604659 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wagner, Siegfried Karl |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Retinal Optical Coherence Tomography Features Associated With Incident and Prevalent Parkinson Disease |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.10.2023 | ||
| 500 | |a Date Revised 17.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. | ||
| 520 | |a BACKGROUND AND OBJECTIVES: Cadaveric studies have shown disease-related neurodegeneration and other morphological abnormalities in the retina of individuals with Parkinson disease (PD); however, it remains unclear whether this can be reliably detected with in vivo imaging. We investigated inner retinal anatomy, measured using optical coherence tomography (OCT), in prevalent PD and subsequently assessed the association of these markers with the development of PD using a prospective research cohort | ||
| 520 | |a METHODS: This cross-sectional analysis used data from 2 studies. For the detection of retinal markers in prevalent PD, we used data from AlzEye, a retrospective cohort of 154,830 patients aged 40 years and older attending secondary care ophthalmic hospitals in London, United Kingdom, between 2008 and 2018. For the evaluation of retinal markers in incident PD, we used data from UK Biobank, a prospective population-based cohort where 67,311 volunteers aged 40-69 years were recruited between 2006 and 2010 and underwent retinal imaging. Macular retinal nerve fiber layer (mRNFL), ganglion cell-inner plexiform layer (GCIPL), and inner nuclear layer (INL) thicknesses were extracted from fovea-centered OCT. Linear mixed-effects models were fitted to examine the association between prevalent PD and retinal thicknesses. Hazard ratios for the association between time to PD diagnosis and retinal thicknesses were estimated using frailty models | ||
| 520 | |a RESULTS: Within the AlzEye cohort, there were 700 individuals with prevalent PD and 105,770 controls (mean age 65.5 ± 13.5 years, 51.7% female). Individuals with prevalent PD had thinner GCIPL (-2.12 μm, 95% CI -3.17 to -1.07, p = 8.2 × 10-5) and INL (-0.99 μm, 95% CI -1.52 to -0.47, p = 2.1 × 10-4). The UK Biobank included 50,405 participants (mean age 56.1 ± 8.2 years, 54.7% female), of whom 53 developed PD at a mean of 2,653 ± 851 days. Thinner GCIPL (hazard ratio [HR] 0.62 per SD increase, 95% CI 0.46-0.84, p = 0.002) and thinner INL (HR 0.70, 95% CI 0.51-0.96, p = 0.026) were also associated with incident PD | ||
| 520 | |a DISCUSSION: Individuals with PD have reduced thickness of the INL and GCIPL of the retina. Involvement of these layers several years before clinical presentation highlight a potential role for retinal imaging for at-risk stratification of PD | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Romero-Bascones, David |e verfasserin |4 aut | |
| 700 | 1 | |a Cortina-Borja, Mario |e verfasserin |4 aut | |
| 700 | 1 | |a Williamson, Dominic J |e verfasserin |4 aut | |
| 700 | 1 | |a Struyven, Robbert R |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Yukun |e verfasserin |4 aut | |
| 700 | 1 | |a Patel, Salil |e verfasserin |4 aut | |
| 700 | 1 | |a Weil, Rimona S |e verfasserin |4 aut | |
| 700 | 1 | |a Antoniades, Chrystalina A |e verfasserin |4 aut | |
| 700 | 1 | |a Topol, Eric J |e verfasserin |4 aut | |
| 700 | 1 | |a Korot, Edward |e verfasserin |4 aut | |
| 700 | 1 | |a Foster, Paul J |e verfasserin |4 aut | |
| 700 | 1 | |a Balaskas, Konstantinos |e verfasserin |4 aut | |
| 700 | 1 | |a Ayala, Unai |e verfasserin |4 aut | |
| 700 | 1 | |a Barrenechea, Maitane |e verfasserin |4 aut | |
| 700 | 1 | |a Gabilondo, Iñigo |e verfasserin |4 aut | |
| 700 | 1 | |a Schapira, Anthony H V |e verfasserin |4 aut | |
| 700 | 1 | |a Khawaja, Anthony P |e verfasserin |4 aut | |
| 700 | 1 | |a Patel, Praveen J |e verfasserin |4 aut | |
| 700 | 1 | |a Rahi, Jugnoo S |e verfasserin |4 aut | |
| 700 | 1 | |a Denniston, Alastair K |e verfasserin |4 aut | |
| 700 | 1 | |a Petzold, Axel |e verfasserin |4 aut | |
| 700 | 1 | |a Keane, Pearse Andrew |e verfasserin |4 aut | |
| 700 | 0 | |a for UK Biobank Eye & Vision Consortium |e verfasserin |4 aut | |
| 700 | 1 | |a Allen, Naomi |e investigator |4 oth | |
| 700 | 1 | |a Aslam, Tariq |e investigator |4 oth | |
| 700 | 1 | |a Atan, Denize |e investigator |4 oth | |
| 700 | 1 | |a Barman, Sarah |e investigator |4 oth | |
| 700 | 1 | |a Barrett, Jenny H |e investigator |4 oth | |
| 700 | 1 | |a Bishop, Paul |e investigator |4 oth | |
| 700 | 1 | |a Black, Graeme |e investigator |4 oth | |
| 700 | 1 | |a Braithwaite, Tasanee |e investigator |4 oth | |
| 700 | 1 | |a Carare, Roxana O |e investigator |4 oth | |
| 700 | 1 | |a Chakravarthy, Usha |e investigator |4 oth | |
| 700 | 1 | |a Chan, Michelle |e investigator |4 oth | |
| 700 | 1 | |a Chua, Sharon Yl |e investigator |4 oth | |
| 700 | 1 | |a Day, Alexander |e investigator |4 oth | |
| 700 | 1 | |a Desai, Parul |e investigator |4 oth | |
| 700 | 1 | |a Dhillon, Bal |e investigator |4 oth | |
| 700 | 1 | |a Dick, Andrew D |e investigator |4 oth | |
| 700 | 1 | |a Doney, Alexander |e investigator |4 oth | |
| 700 | 1 | |a Egan, Cathy |e investigator |4 oth | |
| 700 | 1 | |a Ennis, Sarah |e investigator |4 oth | |
| 700 | 1 | |a Fruttiger, Marcus |e investigator |4 oth | |
| 700 | 1 | |a Gallacher, John Ej |e investigator |4 oth | |
| 700 | 1 | |a Garway-Heath, David F |e investigator |4 oth | |
| 700 | 1 | |a Gibson, Jane |e investigator |4 oth | |
| 700 | 1 | |a Guggeinheim, Jeremy A |e investigator |4 oth | |
| 700 | 1 | |a Hammond, Chris J |e investigator |4 oth | |
| 700 | 1 | |a Hardcastle, Alison |e investigator |4 oth | |
| 700 | 1 | |a Harding, Simon P |e investigator |4 oth | |
| 700 | 1 | |a Hogg, Ruth E |e investigator |4 oth | |
| 700 | 1 | |a Hysi, Pirro |e investigator |4 oth | |
| 700 | 1 | |a Peng T Khaw, Sir |e investigator |4 oth | |
| 700 | 1 | |a Lascaratos, Gerassimos |e investigator |4 oth | |
| 700 | 1 | |a Littlejohns, Thomas |e investigator |4 oth | |
| 700 | 1 | |a Lotery, Andrew J |e investigator |4 oth | |
| 700 | 1 | |a Luben, Robert |e investigator |4 oth | |
| 700 | 1 | |a Luthert, Phil |e investigator |4 oth | |
| 700 | 1 | |a Macgillivray, Tom |e investigator |4 oth | |
| 700 | 1 | |a Mackie, Sarah |e investigator |4 oth | |
| 700 | 1 | |a McGuiness, Bernadette |e investigator |4 oth | |
| 700 | 1 | |a McKay, Gareth J |e investigator |4 oth | |
| 700 | 1 | |a McKibbin, Marin |e investigator |4 oth | |
| 700 | 1 | |a Moore, Tony |e investigator |4 oth | |
| 700 | 1 | |a Morgan, James E |e investigator |4 oth | |
| 700 | 1 | |a O'Sullivan, Eoin |e investigator |4 oth | |
| 700 | 1 | |a Oram, Richard |e investigator |4 oth | |
| 700 | 1 | |a Owen, Chris G |e investigator |4 oth | |
| 700 | 1 | |a Paterson, Euan |e investigator |4 oth | |
| 700 | 1 | |a Peto, Tunde |e investigator |4 oth | |
| 700 | 1 | |a Rudnicka, Alicja R |e investigator |4 oth | |
| 700 | 1 | |a Sattar, Naveed |e investigator |4 oth | |
| 700 | 1 | |a Self, Jay |e investigator |4 oth | |
| 700 | 1 | |a Sergouniotis, Panagiotis |e investigator |4 oth | |
| 700 | 1 | |a Sivaprasad, Sobha |e investigator |4 oth | |
| 700 | 1 | |a Steel, David |e investigator |4 oth | |
| 700 | 1 | |a Stratton, Irene |e investigator |4 oth | |
| 700 | 1 | |a Strouthidis, Nicholas |e investigator |4 oth | |
| 700 | 1 | |a Sudlow, Cathie |e investigator |4 oth | |
| 700 | 1 | |a Sun, Zihan |e investigator |4 oth | |
| 700 | 1 | |a Tapp, Robyn |e investigator |4 oth | |
| 700 | 1 | |a Thomas, Dhanes |e investigator |4 oth | |
| 700 | 1 | |a Trucco, Emanuele |e investigator |4 oth | |
| 700 | 1 | |a Tufail, Adnan |e investigator |4 oth | |
| 700 | 1 | |a Vitart, Veronique |e investigator |4 oth | |
| 700 | 1 | |a Viswanathan, Ananth C |e investigator |4 oth | |
| 700 | 1 | |a Weedon, Mike |e investigator |4 oth | |
| 700 | 1 | |a Williams, Cathy |e investigator |4 oth | |
| 700 | 1 | |a Williams, Katie |e investigator |4 oth | |
| 700 | 1 | |a Woodside, Jayne V |e investigator |4 oth | |
| 700 | 1 | |a Yates, MaxM |e investigator |4 oth | |
| 700 | 1 | |a Yip, Jennifer |e investigator |4 oth | |
| 700 | 1 | |a Zheng, Yalin |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Neurology |d 1951 |g 101(2023), 16 vom: 17. Okt., Seite e1581-e1593 |w (DE-627)NLM000034355 |x 1526-632X |7 nnns |
| 773 | 1 | 8 | |g volume:101 |g year:2023 |g number:16 |g day:17 |g month:10 |g pages:e1581-e1593 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1212/WNL.0000000000207727 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 101 |j 2023 |e 16 |b 17 |c 10 |h e1581-e1593 | ||